Lysosomal Disease Treatment Market, Global Scenario, Market Size, Outlook, Trend, and Forecast, 2017 – 2025
Report Description
Global Lysosomal Disease Treatment Market is expected to grow at a CAGR of 8.4% from 2017 to 2025.The expected growth rate is XX% from 2017 to 2025. The report highlights the key trends, market outlook and the global scenario of the Global Lysosomal Disease Treatment Market. The market sizing is provided from 2017 to 2025, wherein the forecast is provided from 2017 to 2025. In addition, market dynamics (i.e. market drivers, market restraints and market opportunities) which covers factors supporting the market growth, factors restraining the market growth and factors behind the opportunities across this industry in the coming years has been included extensively under the scope of the study. The report also provides extensive detail of the market segments across type, application, and geography; market share of the key players globally and the competitive scenario throughout the forecast period, industry expert opinion, and profiles of the key players in the market. The major key players of the market are as follows:
KEY PLAYERS
ACTELION PHARMACEUTICALS LTD.
AMICUS THERAPEUTICS
ARENA PHARMACEUTICALS INC.
ASTELLAS PHARMA
ASTRAZENECA
BIOMARIN PHARMACEUTICAL INC.
ELI LILLY AND COMPANY
LEXICON PHARMACEUTICALS, INC.
MERCK & CO., INC.
NOVO NORDISK A/S
SANGAMO THERAPEUTICS, INC.
SANOFI GENZYME
SHIRE
Scope of the Market
Disease Type Market
Gauchers
Fabry Disease
Pompe Disease
Mucopolysaccharidosis (MPS)
Others
Route of Administration Market
Oral Route of Administration
Intravenous Route of Administration
End Use Market
Hospitals
Clinics
Others
Treatment Type
Enzyme Replacement Therapy Market
Substrate Reduction Therapy
Geography Market
North America
Europe
Asia Pacific
Rest of the World (RoW)
Payment Options